FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

331164004: Product containing precisely hydrocortisone (as hydrocortisone sodium succinate) 2.5 milligram/1 each conventional release oromucosal lozenge (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3674608013 Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674609017 Product containing precisely hydrocortisone (as hydrocortisone sodium succinate) 2.5 milligram/1 each conventional release oromucosal lozenge (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4715031000005118 hydrocortison 2,5 mg sugetablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Is a hydrocortisonpræparat til topikal anvendelse false Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone false Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hydrocortisone (substance) false Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. binyrehormonmiddel false Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Has manufactured dose form kutan OG/ELLER transdermal doseringsform false Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Has manufactured dose form Oromucosal lozenge true Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Hydrocortisone (substance) true Inferred relationship Some 1
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Has unit of presentation Lozenge true Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Has presentation strength numerator value 2.5 false Inferred relationship Some 1
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge This attribute specifies the denominator unit for the presentation strength of a product. Lozenge true Inferred relationship Some 1
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Has presentation strength denominator value en false Inferred relationship Some 1
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Hydrocortisone sodium succinate true Inferred relationship Some 1
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Is a Hydrocortisone-containing product in oromucosal dose form false Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Count of base of active ingredient en false Inferred relationship Some
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge Is a Product containing only hydrocortisone in oromucosal dose form (medicinal product form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start